Versor Investments’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Versor Investments’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-775,045	Closed	-$72M	–	742
2021 Q4	$72M	Buy	+775,045	New	+$51.1M	2.18%	22

Versor Investments's ARNA Position: Q1 2022 in Review

Versor Investments sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 775,045 shares — an estimated $72M sold.

Versor Investments first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $72M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Versor Investments reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Versor Investments sold 775,045 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $72M.
Versor Investments first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Versor Investments's Arena Pharmaceuticals Inc position peaked at $72M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Versor Investments's 13F filing for Q1 2022, filed 4 May 2022.